366 related articles for article (PubMed ID: 16179524)
1. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
2. [Neuroprotective actions of lithium].
Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
[TBL] [Abstract][Full Text] [Related]
3. Lithium neuroprotection: molecular mechanisms and clinical implications.
Rowe MK; Chuang DM
Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.
Shao L; Young LT; Wang JF
Biol Psychiatry; 2005 Dec; 58(11):879-84. PubMed ID: 16005436
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
Chuang DM
Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
[TBL] [Abstract][Full Text] [Related]
6. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
7. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
[TBL] [Abstract][Full Text] [Related]
9. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
10. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice.
Umeda K; Suemaru K; Todo N; Egashira N; Mishima K; Iwasaki K; Fujiwara M; Araki H
Eur J Pharmacol; 2006 Dec; 553(1-3):157-62. PubMed ID: 17070517
[TBL] [Abstract][Full Text] [Related]
11. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
13. Valproate and neuroprotective effects for bipolar disorder.
Atmaca M
Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
[TBL] [Abstract][Full Text] [Related]
14. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.
Hashimoto R; Hough C; Nakazawa T; Yamamoto T; Chuang DM
J Neurochem; 2002 Feb; 80(4):589-97. PubMed ID: 11841566
[TBL] [Abstract][Full Text] [Related]
15. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
Cui J; Shao L; Young LT; Wang JF
Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
[TBL] [Abstract][Full Text] [Related]
16. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.
Ren M; Leng Y; Jeong M; Leeds PR; Chuang DM
J Neurochem; 2004 Jun; 89(6):1358-67. PubMed ID: 15189338
[TBL] [Abstract][Full Text] [Related]
18. Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades.
Laing JM; Golembewski EK; Wales SQ; Liu J; Jafri MS; Yarowsky PJ; Aurelian L
J Neurosci Res; 2008 Feb; 86(2):378-91. PubMed ID: 17893911
[TBL] [Abstract][Full Text] [Related]
19. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
Plant KE; Anderson E; Simecek N; Brown R; Forster S; Spinks J; Toms N; Gibson GG; Lyon J; Plant N
Toxicol Appl Pharmacol; 2009 Feb; 235(1):124-34. PubMed ID: 19101580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
